Burjeel Holdings reports strong Q1 2023 net profit growth of 43.4%

Burjeel Holdings reports strong Q1 2023 net profit growth of 43.4%

- EBITDA increased 13.4% y-o-y to AED 241.6 million with net profit growth of 43.4% y-o-y to AED 121.3 million, reflecting ongoing operational efficiencies and the shift towards critical, high-value specialties

- Healthy balance sheet position with Net Debt/EBITDA* at 1.4x at the end of the period

- Expansion into Saudi Arabia progressing well through Leejam joint venture.

- Positive outlook and on track to add 120+ new inpatient beds and five new medical centers across UAE

Abu Dhabi, United Arab Emirates: Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading Healthcare Services Provider in the UAE and MENA listed on the Abu Dhabi Securities Exchange (“ADX”) (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced its financial results for the three-month period ended 31 March 2023.

- Net Profit of AED 121.3 million up 43.4% % y-o-y, demonstrating the Group’s improved operational efficiency and a strategic shift towards high-end and specialized services

- Revenue of AED 1.1 billion, up 11.6% y-o-y, driven by 32.6% topline growth at our flagship hospital Burjeel Medical City (BMC)

- EBITDA of AED 241.6 million, up 13.4% y-o-y, with a stable EBITDA margin of 22.3%

- Outpatient footfall and inpatient footfall saw a strong increase of 16.5% and 26.9%, respectively, primarily due to the Group's